Multimarker strategy for the prediction of 31 days cardiac death in patients with acutely decompensated chronic heart failure

International Journal of Cardiology

Volumn 141, Issue 3, 2010, Pages 284-290

  Zairis, Michael N ^a   Tsiaousis, George Z ^a   Georgilas, Anastassios Theodossis ^a   Makrygiannis, Stamatis S ^a   Adamopoulou, Evdokia N ^a   Handanis, Stelios M ^a   Batika, Pelagia C ^a   Prekates, Athanasios A ^a   Velissaris, Dimitris ^b   Kouris, Nikolaos T ^c   Mytas, Demetrios Z ^d   Babalis, Demetrios K ^c   Karidis, Kostas S ^d   Foussas, Stefanos G ^a  

^a TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

^b UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^c Western Attika Hospital   (Greece)

^d SOTIRIA GENERAL HOSPITAL   (Greece)

Author keywords

Acute decompensation; Chronic heart failure; Mortality; Multimarker strategy

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; TROPONIN I;

AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; DISEASE MARKER; DISEASE SEVERITY; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART DEATH; HEART FAILURE; HOSPITAL ADMISSION; HUMAN; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; REGRESSION ANALYSIS; RISK ASSESSMENT;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIAC OUTPUT; CHRONIC DISEASE; DEATH, SUDDEN, CARDIAC; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; MALE; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; ROC CURVE; SEVERITY OF ILLNESS INDEX; TROPONIN I;

EID: 77952742174     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.12.017     Document Type: Article

References (22)

1. Stewart S., MacIntyre K., Capewell S., and McMurray J.J. Heart failure and the aging population: an increasing burden in the 21st century?. Heart 89 (2003) 49-53
2. Haldeman G.A., Croft J.B., Giles W.H., and Rashidee A. Hospitalization of patients with heart failure: national hospital discharge survey, 1985 to 1995. Am Heart J 137 (1999) 352-360
3. Koelling T.M., Chen R.S., Lubwama R.N., L'Italien G.J., and Eagle K.A. The expanding national burden of heart failure in the United States: the influence of heart failure in women. Am Heart J 147 (2004) 74-78
4. Cowie M.R., Fox K.F., Wood D.A., et al. Hospitalization of patients with heart failure: a population-based study. Eur Heart J 23 (2002) 877-885
5. Shahar E., Lee S., Kim J., Duval S., Barber C., and Luepker R.V. Hospitalized heart failure: rates and long-term mortality. J Card Fail 10 (2004) 374-379
6. Braunwald E. Biomarkers in heart failure. N Engl J Med 358 (2008) 2148-2159
7. Suttner W.S., and Boldt J. Natriuretic peptide system: physiology and clinical utility. Curr Opin Crit Care 10 (2004) 336-341
8. Cheng V., Kazanagra R., Garcia A., et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol 37 (2001) 386-391
9. Verdiani V., Nozzoli C., Bacci F., et al. Pre-discharge B-type natriuretic peptide predicts early recurrence of decompensated heart failure in patients admitted to a general medical unit. Eur J Heart Fail 7 (2005) 566-571
10. Logeart D., Thabut G., Jourdain P., et al. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol 43 (2004) 635-641
11. Feng J., Schaus B.J., Fallavollita J.A., Lee T.C., and Canty Jr. J.M. Preload induces troponin I degradation independently of myocardial ischemia. Circulation 103 (2001) 2035-2037
12. La Vecchia L., Mezzena G., Zanolla L., et al. Cardiac troponin I as diagnostic and prognostic marker in severe heart failure. J Heart Lung Transplant 19 (2000) 644-652
13. Perna E.R., Macín S.M., Cimbaro Canella J.P., et al. Minor myocardial damage detected by troponin T is a powerful predictor of long-term prognosis in patients with acute decompensated heart failure. Int J Cardiol 99 (2005) 253-261
14. Ishii J., Nomura M., Nakamura Y., et al. Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure. Am J Cardiol 89 (2002) 691-695
15. Peacock IV W.F., De Marco T., Fonarow G.C., et al. Cardiac troponin and outcome in acute heart failure. N Engl J Med 358 (2008) 2117-2126
16. Sato Y., Takatsu Y., Kataoka K., et al. Serial circulating concentrations of C-reactive protein, interleukin IL-4, and IL-6 in patients with acute left heart decompensation. Clin Cardiol 22 (1999) 811-813
17. Peschel T., Schonauer M., Thiele H., Anker S.D., Schuler G., and Niebauer J. Invasive assessment of bacterial endotoxin and inflammatory cytokines in patients with acute heart failure. Eur J Heart Fail 5 (2003) 609-614
18. Milo O., Cotter G., Kaluski E., et al. Comparison of inflammatory and neurohormonal activation in cardiogenic pulmonary edema secondary to ischemic versus nonischemic causes. Am J Cardiol 92 (2003) 222-227
19. Narang R., Cleland J.G., Erhardt L., et al. Mode of death in chronic heart failure. A request and proposition for more accurate classification. Eur Heart J 17 (1996) 1390-1403
20. Horwich T.B., Patel J., MacLellan W.R., and Fonarow G.C. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 108 (2003) 833-838
21. Hamada Y., Tanaka N., Murata K., et al. Significance of predischarge BNP on one-year outcome in decompensated heart failure-comparative study with echo-Doppler indexes. J Card Fail 11 (2005) 43-49
22. Coats A.J. Ethical authorship and publishing. Int J Cardiol 131 (2009) 149-150